These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Aulakh GK, Sodhi RK, Singh M. Life Sci; 2007 Aug 02; 81(8):615-39. PubMed ID: 17692338 [Abstract] [Full Text] [Related]
27. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension. Sanoski CA. Pharmacotherapy; 2009 Feb 02; 29(2):193-212. PubMed ID: 19170589 [Abstract] [Full Text] [Related]
30. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient? de la Sierra A, Salazar J. Adv Ther; 2011 Sep 02; 28(9):716-27. PubMed ID: 21809181 [Abstract] [Full Text] [Related]
31. Aliskiren in the treatment of hypertension and organ damage. Riccioni G. Cardiovasc Ther; 2011 Feb 02; 29(1):77-87. PubMed ID: 21106033 [Abstract] [Full Text] [Related]
32. Aliskiren: an oral renin inhibitor for the treatment of hypertension. Lam S, Choy M. Cardiol Rev; 2007 Feb 02; 15(6):316-23. PubMed ID: 18090068 [Abstract] [Full Text] [Related]
34. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension. Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL. J Renin Angiotensin Aldosterone Syst; 2008 Sep 02; 9(3):163-75. PubMed ID: 18957387 [Abstract] [Full Text] [Related]